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Abstract
 
We generated T cell receptor transgenic mice specific for the liver stages of the rodent malaria
parasite 
 
Plasmodium yoelii
 
 and studied the early events in the development of in vivo effector
functions in antigen-specific CD8
 

 
 T cells. Differently to activated/memory cells, naive CD8
 

 
T cells are not capable of exerting antiparasitic activity unless previously primed by parasite im-
munization. While naive cells need to differentiate before achieving effector status, the time re-
quired for this process is very short. Indeed, interferon (IFN)-
 
 
 
and perforin mRNA are detect-
able 24 h after immunization and IFN-
 

 
 secretion and cytotoxic activity are detected ex vivo 24
and 48 h after immunization, respectively. In contrast, the proliferation of CD8
 

 
 T cells begins
after 24 h and an increase in the total number of antigen-specific cells is detected only after 48 h.
Remarkably, a strong CD8
 

 
 T cell–mediated inhibition of parasite development is observed in
mice challenged with viable parasites only 24 h after immunization with attenuated parasites.
These results indicate that differentiation of naive CD8
 

 
 T cells does not begin only after exten-
sive cell division, rather this process precedes or occurs simultaneously with proliferation.
Key words: malaria • CD8
 

 
 T cells • TCR transgenic mouse • effector T cell • in vivo 
differentiation
 
Introduction
 
Naive and memory CD8
 

 
 T cells differ greatly with regards
to their capacity to respond to antigenic stimulation. Acti-
vated/memory T cells secrete cytokines and proliferate
immediately after antigen recognition. In contrast, naive
CD8
 

 
 T cells undergo a series of phenotypic changes before
differentiating into effector cells (1, 2). The mechanisms in-
volved in the in vivo development of effector functions in
naive CD8
 

 
 T cells still remain poorly understood. Indeed,
the basic features of this T cell response, such as the time
frame and sequence of events involved in the differentiation
and proliferation of naive cells activated after infection by
intracellular pathogens, have yet to be defined.
In rodent malaria models, it is well established that
CD8
 

 
 T cells induced after immunization with attenuated
or viable malaria sporozoites play an important role in pro-
tection against liver stages of this parasite. This has been
demonstrated in adoptive transfer experiments using CD8
 

 
T cell clones specific for defined malaria epitopes that in-
hibit parasite development in the liver, thus preventing the
onset of blood-stage infection (3, 4). Moreover, immuniza-
tion with subunit vaccines based on recombinant viruses or
DNA-expressing MHC class I–restricted malaria epitopes
induces a strong parasite-specific CD8
 

 
 T cell response that
protects against parasite challenge (5–8). Overall, these
studies demonstrate that in the malaria system, unlike most
infectious models, CD8
 

 
 T cells exert such a strong anti-
parasitic effect that T cell responses against a single epitope
can eliminate infection.
The induction of CD8
 

 
 T cells against the liver stages of
malaria parasites differs from T cell responses to most infec-
tious organisms. Soon after 
 
Plasmodium yoelii
 
 sporozoites in-
vade hepatocytes, they undergo extensive transformation
and about 44 h later, a distinct parasite stage, displaying a dif-
ferent antigenic make-up, is released from the liver and in-
vade red blood cells. Since parasites from erythrocytic stages
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do not reinvade hepatocytes, the CD8
 

 
 T cell response
against the liver stages is the result of a single and short-lived
infectious event. In contrast, the CD8
 

 
 T cell responses to
bacterial and viral infections are “shaped” by repeated over-
lapping cycles of infection and reinfection, generating a mix-
ture of cell populations in different stages of differentiation.
A major limitation in analyzing the early in vivo events
leading to the development of effector CD8
 

 
 T cells
against malaria is the low frequency of precursors for spe-
cific epitopes. To overcome this limitation, we generated
transgenic mice expressing a TCR specific for the H2K
 
d
 
-
restricted epitope, SYVPSAEQI, located in the 
 
P. yoelii
 
circumsporozoite protein (amino acids 252–260). This
epitope is recognized by CD8
 

 
 but not by CD4
 

 
 T cells
(5). Using this transgenic system, we sought to define the
early events involved in the development of effector func-
tions and acquisition of protective antiparasitic activity in
naive malaria-specific CD8
 

 
 T cells.
 
Materials and Methods
 
Parasites and Mice. P. yoelii
 
 (17X NL strain) and 
 
P. berghei
 
(NK65) sporozoites were obtained as described previously (4).
Normal BALB/c, C57Bl/6, or CB6/F1 mice were purchased
from the National Cancer Institute.
Transgenic mice were generated based on the rearranged V(D)J
segments of the TCR-
 

 
 and -
 

 
 genes of the CD8
 

 
 T cell clone
YA26, which is specific for SYVPSAEQI, a CD8
 

 
 T cell epitope
located in the 
 
P. yoelii
 
 circumsporozoite protein (4). A cDNA
library was constructed (Express cDNA Gigapack II Gold; Strat-
agene) from YA26 and the TCR genes were screened using 
 
32
 
[P]-
labeled probes from each conserved regions: 5
 

 
-TGTTCACCG-
ACTTTGACTCC-3
 

 
; 5
 

 
-TGGCGTTGGTCTCTTTGAAG-3
 

 
(for C
 

 
); 5
 

 
-TGAGAAATGTGACTCCACCC-3
 

 
; and 5
 

 
-CTG-
CTCAGGCAGTAGCTATA-3
 

 
 (for C
 

 
). After genomic am-
plification of the positive clones, the rearranged genes were deter-
mined to be V
 

 
10 and V
 

 
8.1. The TCR-
 

 
 and -
 

 
 transgenes
were constructed by inserting the identified rearranged genomic
sequences into TCR-
 

 
 and -
 

 
 cassette vectors (9) using the fol-
lowing primers: 5
 

 
-CCGCCCGGGCCACAGCCCAGGGAC-
TGGTTACTTGC-3
 

 
; 5
 

 
-TCCCCGCGGTGTGGTCGTCTG-
TGTGATAAAGGCTATGAG-3
 

 
 (for 
 

 
); 5
 

 
-CCGCTCGAG-
GAGAAGTGGTGGAGTGTCTTAACTGTGCAG-3
 

 
; and 5
 

 
-
TCCCCGCGGTCCTTAGCCTGGGAAATGCTCCC-3
 

 
 (for
 

 
). The underlined nucleotides represent restriction enzyme sites
used for cloning. The transgenes were coinjected into C57BL/6
oocytes and the resulting transgenic mice were identified by PCR
screening of genomic DNA isolated from tails. Since the SYVP-
SAEQI epitope is H2
 
d
 
-restricted, TCR transgenic C57BL/6 mice
were crossed with BALB/c mice and the resulting CB6/F1–
expressing H2K
 
b/d
 
 were used for subsequent experiments.
 
Tetramers, Antibodies, and 5-Carboxyfluorescein Diacetate Succi-
nimidyl Ester Staining.
 
SYVPSAEQI-specific H2K
 
d
 
 tetramers
were prepared as described previously (10). Antibodies to mouse
CD8 (53-6.7), CD11a (M17/4), CD44 (IM-7), and CD122
(TM-
 

 
1) were obtained from BD PharMingen. 5-carboxyfluores-
cein diacetate succinimidyl ester (CFSE)
 
*
 
 staining was performed
based on the manufacturer’s instructions (Molecular Probes).
 
Adoptive Transfers, Immunizations, and Parasite Challenge.
 
Spleen
cells from transgenic mice containing 1–2 
 
 
 
10
 
6
 
 CD8
 

 
 tetramer
 

 
cells, unless otherwise specified, were used for adoptive transfers.
The total number of transgenic cells used in the experiments was
determined by FACS
 
®
 
 (Becton Dickinson) analysis after staining
spleen cells for CD8 and with SYVPSAEQI-tetramers.
Sporozoite immunizations, done 24 h after adoptive transfer,
were performed by intravenous injection of 5 
 

 
 10
 
4
 
 radiation-
attenuated sporozoites (
 

 
-source, 20 Krad). Other mice were im-
munized intraperitoneally with 10
 
6
 
 plaque forming units of a re-
combinant vaccinia virus expressing the 9-mer SYVPSAEQI
epitope (5).
Challenge of mice was performed by intravenous injection of
5 
 

 
 10
 
4
 
 viable (nonirradiated) 
 
P. yoelii
 
 sporozoites. Quantifica-
tion of parasite load in the livers of mice after challenge was per-
formed as described previously (11). This competitive reverse
transcription (RT)-PCR is based on the use of primers specific
for 
 
Plasmodium 
 
18s rRNA that amplify a 393-bp fragment in total
parasite RNA but not in mouse RNA. As competitor, a trun-
cated cloned 333-bp 
 
Plasmodium
 
 rRNA fragment, was used in all
assays.
 
ELISPOT and Cytotoxic Assay.
 
The determination of indi-
vidual SYVPSAEQI-specific IFN-
 

 
–secreting CD8
 

 
 T cells by
ELISPOT was performed as described previously (12). The ex
vivo cytotoxic assay was performed using a standard 
 
51
 
Cr release
assay as described previously (10).
 
Quantification of Mouse IFN-
 

 
 and Perforin mRNA Transcripts.
 
SYVPSAEQI-specific tetramer
 

 
 cells were purified from the
spleens of mice receiving transgenic CD8
 

 
 T cells using anti-PE
antibodies bound to magnetic beads following the manufacturer’s
instructions (Miltenyi Biotec). Total RNA was extracted using
standard guanidinium thiocyanate phenol/chloroform extraction.
mRNA transcripts for mouse IFN-
 

 
 and perforin were amplified
using specific primers in quantitative RT-PCR as described pre-
viously (13–15). The total amounts of IFN-
 
 
 
and perforin
mRNA were determined by densitometry using a GelDoc 2000
system and Quantity One
 
®
 
 software (Bio-Rad Laboratories).
 
Results and Discussion
 
Specificity of TCR Transgenic Mice.
 
To assess the speci-
ficity of the TCR transgenic CD8
 

 
 T cells, we analyzed
spleen cells by FACS
 
®
 
, after staining for CD8 and with
SYVPSAEQI-specific H2K
 
d
 
 tetramers (10). As shown in
Fig. 1 A, a large number of CD8
 

 
 T cells from the trans-
genic mice bind the SYVPSAEQI-tetramers. As expected,
CD4
 

 
 T cells from these mice do not bind the tetramers,
in agreement with previous studies indicating that CD4
 

 
 T
cells do not recognize this epitope (5).
The specificity of the transgenic CD8
 

 
 T cells was fur-
ther studied after adoptive transfer into normal mice fol-
lowed by immunization with radiation-attenuated 
 
P. yoelii
 
sporozoites. The CD8
 

 
 T cell response was evaluated using
ELISPOT to detect IFN-
 

 
 secretion using SYVPSAEQI-
coated target cells (12). As shown in Fig. 1 B, in mice re-
ceiving transgenic cells, a large number of IFN-
 

 
–secreting
cells are detected after immunization with 
 
P. yoelii
 
 sporo-
zoites. In contrast, negligible numbers of cells are detected
in recipient mice which were not immunized or immu-
nized with 
 
P. berghei
 
 sporozoites, a related malaria parasite
expressing a noncross reacting CD8
 

 
 T cell epitope, SYIP-
 
*
 
Abbreviations used in this paper:
 
 CFSE, 5-carboxyfluorescein diacetate suc-
cinimidyl ester; RT, reverse transcription.
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SAEKI (4). The IFN-–secreting cells detected in mice
that did not receive transgenic cells but were immunized
with P. yoelii sporozoites represent the response of endoge-
nous anti-SYVPSAEQI specific CD8 T cells (Fig. 1 B).
Induction of In Vivo Effector Functions and Proliferation of
CD8 T Cells. As determined by FACS® after tetramer
staining of CD8 T cells from spleens of immunized recip-
ient mice, a significant increase in the frequency of SYVP-
SAEQI-specific CD8 T cells is evident 72 h after im-
munization (Fig. 2 A). The evolution of this response,
monitored by FACS® and ELISPOT, shows that it peaks at
days 4–5 and decreases rapidly thereafter. After day 8, the
magnitude of the CD8 T cell response is stabilized and re-
mains unchanged for several weeks (Fig. 2 B). The sudden
decrease in the number of antigen-specific T cells after the
initial antigen-driven expansion has been observed in other
infectious systems and has been suggested to be caused by
programmed cell death (16–19). In spite of the dramatic
decrease in the frequency of CD8 T cells, those cells that
remain after day 15 are fully capable of mediating protec-
tion against challenge with P. yoelii sporozoites (data not
shown).
To further study the differentiation of naive CD8 T
cells to effector cells, we determined the transcriptional
changes in the levels of both IFN- and perforin in naive
cells after immunization. Total RNA was isolated from
tetramer cells purified by magnetic beads 24 h after im-
munization. As analyzed by RT-PCR (Fig. 3, A and B), a
significant induction of IFN- and perforin mRNA is de-
tected in SYVPSAEQI-specific CD8 T cells at 24 h as
compared with controls. Moreover, antigen-specific secre-
tion is clearly detectable in an ex vivo ELISPOT assay us-
Figure 1. Phenotypic and func-
tional specificity of the transgenic
CD8 T cells. (A) CD8 T cells
from transgenic CB6/F1 mice
bind to SYVPSAEQI-tetramers.
Plots were analyzed on live lym-
phocytes and the numbers indi-
cated the frequency of CD8
tetramer cells in total lympho-
cytes. (B) Adoptively transferred
transgenic CD8 T cells are acti-
vated only after immunization with radiation-attenuated P. yoelii sporozoites. The frequencies of SYVP-
SAEQI-specific IFN-–secreting cells in the spleen were determined by ELISPOT, 8 d after immuniza-
tion, in the presence of SYVPSAEQI-coated target cells. Nonimmunized recipient mice and immunized
normal mice were also used as controls. Results are expressed as average  SD of duplicate cultures. Neg-
ligible numbers of spots are obtained using control target cells (data not shown).
Figure 2. Activation kinetics of antigen-activated naive CD8 T cells. (A) Spleen cells from immunized and nonimmunized recipient mice were iso-
lated at 24, 48, and 72 h and stained for CD8 and with SYVPSAEQI-specific tetramers. Plots were analyzed on live lymphocytes and the numbers indi-
cated represent the frequency of CD8 tetramer T cells in total lymphocytes. (B) Spleen cells from immunized and nonimmunized recipient mice were
analyzed by ELISPOT and tetramer staining on days 0, 2, 3, 4, 5, 6, 8, 10, 13, and 18 after immunization. Results are expressed as absolute number of
SYVPSAEQI-specific CD8 T cells per spleen calculated as the frequencies obtained by either ELISPOT (, ) or tetramer staining (,  ) multiplied
by the total number of cells obtained after spleen excision. Filled symbols represent data from immunized mice and open symbols represent data from
nonimmunized mice.
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ing spleen cells of recipient mice immunized 24 h earlier
(Fig. 3 C). Based on the frequency of tetramer cells deter-
mined by FACS® and the results of ELISPOT, we estimate
that the population of cells secreting INF- at 24 h repre-
sents 2–4% of the SYVPSAEQI-specific T cells. Further-
more, ex vivo cytotoxic activity by SYVPSAEQI-specific
CD8 T cells is detectable 48 h immunization, as assessed
by an ex vivo 51Cr release assay (Fig. 3 D). CD8 T cells
obtained from recipient mice that were not immunized did
not secrete INF- and did not display cytotoxic activity.
Since malaria sporozoites invade and develop in hepato-
cytes, we also studied the presence of activated CD8 T
cells in the liver during the course of immunization (20).
We found that these cells are also detected in the liver 24 h
after immunization, although their frequency is much
lower than in the spleen (Fig. 3 C).
Antigen-activated cells also undergo early surface phe-
notype changes. We determined by FACS® that the
CD8 tetramer T cells used for adoptive transfer display
CD11alo, CD122lo, and CD44lo surface phenotype (data
not shown), characteristic of naive cells (21–23). 24 h after
immunization, 30% of the CD8 tetramer cells already
express higher levels of CD44 (Fig. 3 E), and 48–72 h later
most of these T cells become CD11ahi CD122hi (data not
shown).
To determine the relationship between the proliferation
of activated CD8 T cells and the differentiation pattern
described above, transgenic CD8 T cells were labeled
with CFSE (1) and transferred into normal mice that were
immunized with radiation-attenuated sporozoites. Every
24 h, mice were killed and the proliferative status of the la-
beled CD8 tetramer T cells was determined by evaluat-
Figure 3. Rapid acquisition of ef-
fector functions and phenotypic acti-
vation in antigen-activated naive
CD8 T cells. (A and B) Tetramer
spleen cells from immunized and
nonimmunized recipient mice were
isolated at 24 h and total mRNA was
processed for RT-PCR to measure
IFN- perforin and hypoxanthine ri-
bosyltransferase (HPRT) as internal
control (data not shown, and refer-
ence 15). The results are expressed as
average  SD of the amount of re-
spective transcript per 106 tetramer cells. (C) Spleen and intrahepatic cells from
immunized and nonimmunized (data not shown) recipient mice were isolated at 0,
24, and 48 h and analyzed by ELISPOT. Results are expressed as average  SD of
duplicate cultures. (D) 51Cr release assay using spleen cells from recipient mice ob-
tained 48 h after immunization. Results are expressed as specific lysis at different
target ratios of CD8 T cells to SYVPSAEQI-coated target cells. Cells from im-
munized mice (, ) and nonimmunized mice (, ) were incubated 6 h with
peptide-coated target cells (filled symbols) or target cells without peptide (open
symbols). (E) Spleen cells from immunized and nonimmunized recipient mice
stained for CD8 and CD44, and with SYVPSAEQI tetramers. Dark lines represent
cells obtained at 0 h, while light lines represent cells obtained at 24 h. Histograms
are gated on live CD8 tetramer T cells.
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ing the dilution of CFSE stain. As shown in Fig. 4, a mas-
sive proliferative activity of activated CD8 tetramer cells
is observed 48 h after immunization and it proceeds rapidly
over the next 24 h. In the absence of immunization, the
proliferation of these cells is negligible. It is worth noting
that, as determined by FACS® (Fig. 2 A), a significant in-
crease in the total number of SYVPSAEQI-specific CD8
T cells is detected only after 48 h, thus suggesting that the
proliferative activity initiated between 24 and 48 h involve
a small number of cells.
In Vivo Protective Activity of CD8 T Cells. In view of
these results, we compared the in vivo antiparasitic activity
of naive and activated T cells. Activated/memory CD8 T
cells were obtained from recipient mice immunized with a
recombinant vaccinia virus expressing the 9-mer epitope
SYVPSAEQI (5). Equal numbers of naive or activated/
memory CD8 tetramer T cells were transferred into
normal mice that were immediately challenged with viable
P. yoelii sporozoites. After 40 h, the livers were excised and
the parasite load determined using RT-PCR that measures
parasite rRNA (11). As shown in Fig. 5 A, only mice
which received activated/memory T cells were capable of
strongly inhibiting parasite development.
These results clearly demonstrate that naive CD8 T
cells are incapable of exerting antiparasitic activity unless
they are previously activated by antigen. Surprisingly how-
ever, this activation process is very rapid. This was deter-
mined in experiments designed to define the minimal time
required for naive CD8 T cells to become capable of
eliminating parasites. For this purpose, mice receiving naive
cells were immunized with attenuated P. yoelii sporozoites
and at various time points after immunization, mice were
challenged with viable sporozoites and the parasite loads
Figure 4. In vivo proliferation of antigen-activated naive CD8 T
cells. CFSE-labeled spleen cells from transgenic mice were transferred
into normal mice and immunized with P. yoelii sporozoites. Spleen cells
were isolated 24, 48, and 72 h after immunization and stained for CD8
and with SYVPSAEQI-tetramers. Spleen cells from nonimmunized mice
were used as controls. Histograms are shown as CFSE dilution patterns
gated on live lymphocytes and CD8 tetramer T cells.
Figure 5. In vivo antiparasitic activity of CD8 T cells.
(A) Equal numbers of naive or activated/memory CD8
tetramer T cells were transferred into normal mice and
challenged with viable sporozoites. Activated/memory
cells were obtained from recipient mice immunized with
a recombinant vaccinia virus expressing the 9-mer
SYVPSAEQI epitope at day 7. The parasite loads in the
livers were measured by RT-PCR 40 h after challenge.
The results are expressed as the average amount of para-
site rRNA  SD of three mice calculated based on com-
petitor values. Numbers in parenthesis indicate the aver-
age percentage of inhibition compared with parasite load
detected in normal mice. (B) The antiparasitic activity of
activated CD8 T cells is detectable in mice challenged
24 h after immunization. Mice receiving varying amounts
of naive CD8 tetramer T cells were immunized with
attenuated sporozoites and 24 h later, challenged with vi-
able sporozoites. The parasite loads in the livers were de-
termined as described previously.
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were measured 40 h later (11). Parasite development was
not affected in mice challenged 12 h after immunization
(data not shown). In contrast, a strong protective antipara-
sitic response was observed in mice challenged 24 h after
immunization (Fig. 5 B). This protection closely depends
on the number of cells transferred into mice, as the transfer
6  106 CD8 tetramer T cells exerts a strong antipara-
sitic effect while four and eight times less T cells conferred
a reduced or a nonsignificant degree of protection, respec-
tively.
Taken together, the present results highlight the striking
differences between naive and activated/memory CD8 T
cells. Naive cells require antigen priming and a differentia-
tion period before developing the mechanisms allowing
them to exert in vivo antiparasitic activity. This is in sharp
contrast with activated/memory cells, which secrete IFN-
only 6 h after incubation with antigen (17), and as demon-
strated in this study, exert their protective activity immedi-
ately after parasite infection. These results support the no-
tion that there are fundamental differences between naive
and memory T cells regarding their pattern of activation
and differentiation (1, 2, 23).
However, it was surprising that the time required for the
generation of effector CD8 T cells is rather short, as IFN-
and perforin mRNA are detected 24 h after immunization,
and IFN- secretion and cytotoxic activity are detected ex
vivo 24 and 48 h after immunization, respectively. The
speed at which these effector mechanisms are developed is
not a result of T cells already activated before transfer, due
to cross-reactivity with peptides of environmental origin or
to nonspecific activation as observed in lymphopenic mice
(24–26). In our system, we have clearly shown that trans-
genic T cells transferred into normal mice are naive as de-
fined by their surface phenotype and their inability to pro-
duce IFN- or exert cytotoxic activity. Furthermore, we
showed that transferred CD8 T cells can be activated and
proliferate in vivo only when recipient mice are immu-
nized with P. yoelii sporozoites expressing the epitope
SYVPSAEQI, but not with P. berghei sporozoites.
Our results indicating that the development of effector
functions in naive CD8 T cells begins in the absence of
detectable proliferation suggests that differentiation of these
cells is a process that precedes or develops simultaneously
with cell proliferation. These findings challenge the current
notion that CD8 T cell differentiation occurs only after
eight or more cell divisions (27). These also indicate that
the limited efficacy of primary CD8 T cell responses
against malaria parasites or other pathogens is not due to
the time it takes for naive cells to achieve an effector status.
In fact, although activated/memory CD8 T cells appear
to exert their protective activity immediately after antigen
recognition, naive CD8 T cells are capable of developing
this capacity only 24 h later. Therefore, it appears that a
more important factor limiting the protective activity of
primary CD8 T cells responses is the low frequency of an-
tigen-specific precursors present before immunization. This
is indicated by the experiments in which we determined
that while CD8 T cell develop protective effector mecha-
nisms 24 h after immunization, their antiparasitic activity
strictly depended on the number of naive CD8 T cell pre-
cursors transferred into mice before immunization.
Thus, as CD8 T cell differentiation is induced rapidly,
the magnitude and efficacy of primary and memory CD8
T cell responses appears to be more closely determined by
the total number of effectors cells capable of inhibiting par-
asite development. The number of these effector cells is
greatly increased by the proliferation induced after antigen
recognition, while it is severely reduced by mechanisms in-
ducing massive cell death after the CD8 T cell response
reaches a peak. A better understanding of these mechanisms
with opposite functional effects should facilitate their ma-
nipulation and thus, open new avenues for the design and
development of vaccines against malaria and other intracel-
lular pathogens.
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